Journal article icon

Journal article

Covalent targeting of remote cysteine residues to develop CDK12 and 13 inhibitors

Abstract:

Cyclin-dependent kinases 12 and 13 (CDK12 and CDK13) play critical roles in the regulation of gene transcription. However, the absence of CDK12 and CDK13 inhibitors has hindered the ability to investigate the consequences of their inhibition in healthy cells and cancer cells. Here we describe the rational design of a first-in-class CDK12 and CDK13 covalent inhibitor, THZ531. Co-crystallization of THZ531 with CDK12–cyclin K indicates that THZ531 irreversibly targets a cysteine located outside ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/nchembio.2166

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Genomics Consortium
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Genomics Consortium
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Genomics Consortium
Role:
Author
More from this funder
Funding agency for:
Young, R
Gray, N
Grant:
CA109901
5 R01 CA179483-02 C
More from this funder
Funding agency for:
Geyer, M
Grant:
GE 976/9-1
More from this funder
Funding agency for:
Kwiatkowski, N
Young, R
Gray, N
Grant:
CA109901
5 R01 CA179483-02 C
More from this funder
Funding agency for:
Dixon-Clarke, S
Publisher:
Nature Publishing Group Publisher's website
Journal:
Nature Chemical Biology Journal website
Volume:
12
Pages:
876-884
Publication date:
2016-08-29
Acceptance date:
2016-05-13
DOI:
EISSN:
1552-4469
ISSN:
1552-4450
Keywords:
Pubs id:
pubs:627889
UUID:
uuid:9d39c81e-0d3a-407a-9fb0-c128870235ab
Local pid:
pubs:627889
Source identifiers:
627889
Deposit date:
2016-06-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP